There's some good news about Wegovy and Ozempic nausea: It should get better
CrossRef Current status of research on the risk factors and pathogenesis of metabolic dysfunction-associated steatotic liver disease Dan Chen, Lingling Yan, Tong Wu, Junpeng Zhao, Xuebing Xu, Weisong Xu, Hong Zhang, Mingbing Xiao Frontiers in Endocrinology .2026;[Epub] CrossRef Patatin-Like Phospholipase Domain-Containing Protein 3 rs2896019 and MASLD Susceptibility and Severity in Adults: A Systematic Review and Meta-Analysis of CaseControl Studies Wei-Yue Lim, Rosmawati Mohamed, Yuh-Fen Pung, Hak-Keith Leung, Rong-Xiang Ng, Shamsul Mohd Zain Metabolic Syndrome and Related Disorders .2026
Tirzepatide led to even more weight loss
Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial
Body Recomposition: Focus on losing fat and gaining muscle for a toned and sculpted physique
For now, semaglutides impact on food noise may be one more reason its become such a widely discussed and debated treatment
